United States Multiple Sclerosis Drugs Market Report 2016

November 2016 | 96 pages | ID: UE0845BB244EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Multiple Sclerosis Drugs

Revenue, means the sales value of Multiple Sclerosis Drugs

This report studies sales (consumption) of Multiple Sclerosis Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Biogen
• Teva Pharmaceutical
• Merck KGaA
• Novartis
• Bayer
• Sanofi
• Acorda Therapeutics
• Questcor Pharmaceuticals

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Multiple Sclerosis Drugs in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Multiple Sclerosis Drugs Market Report 2016

1 MULTIPLE SCLEROSIS DRUGS OVERVIEW

1.1 Product Overview and Scope of Multiple Sclerosis Drugs
1.2 Classification of Multiple Sclerosis Drugs
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Multiple Sclerosis Drugs
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Multiple Sclerosis Drugs (2011-2021)
  1.4.1 United States Multiple Sclerosis Drugs Sales and Growth Rate (2011-2021)
  1.4.2 United States Multiple Sclerosis Drugs Revenue and Growth Rate (2011-2021)

2 UNITED STATES MULTIPLE SCLEROSIS DRUGS COMPETITION BY MANUFACTURERS

2.1 United States Multiple Sclerosis Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Multiple Sclerosis Drugs Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Multiple Sclerosis Drugs Average Price by Manufactures (2015 and 2016)
2.4 Multiple Sclerosis Drugs Market Competitive Situation and Trends
  2.4.1 Multiple Sclerosis Drugs Market Concentration Rate
  2.4.2 Multiple Sclerosis Drugs Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES MULTIPLE SCLEROSIS DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Multiple Sclerosis Drugs Sales and Market Share by Type (2011-2016)
3.2 United States Multiple Sclerosis Drugs Revenue and Market Share by Type (2011-2016)
3.3 United States Multiple Sclerosis Drugs Price by Type (2011-2016)
3.4 United States Multiple Sclerosis Drugs Sales Growth Rate by Type (2011-2016)

4 UNITED STATES MULTIPLE SCLEROSIS DRUGS SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Multiple Sclerosis Drugs Sales and Market Share by Application (2011-2016)
4.2 United States Multiple Sclerosis Drugs Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES MULTIPLE SCLEROSIS DRUGS MANUFACTURERS PROFILES/ANALYSIS

5.1 Biogen
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Multiple Sclerosis Drugs Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Biogen Multiple Sclerosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Teva Pharmaceutical
  5.2.2 Multiple Sclerosis Drugs Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Teva Pharmaceutical Multiple Sclerosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Merck KGaA
  5.3.2 Multiple Sclerosis Drugs Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Merck KGaA Multiple Sclerosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Novartis
  5.4.2 Multiple Sclerosis Drugs Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Novartis Multiple Sclerosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Bayer
  5.5.2 Multiple Sclerosis Drugs Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Bayer Multiple Sclerosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Sanofi
  5.6.2 Multiple Sclerosis Drugs Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Sanofi Multiple Sclerosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Acorda Therapeutics
  5.7.2 Multiple Sclerosis Drugs Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Acorda Therapeutics Multiple Sclerosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Questcor Pharmaceuticals
  5.8.2 Multiple Sclerosis Drugs Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Questcor Pharmaceuticals Multiple Sclerosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview

6 MULTIPLE SCLEROSIS DRUGS MANUFACTURING COST ANALYSIS

6.1 Multiple Sclerosis Drugs Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Multiple Sclerosis Drugs

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Multiple Sclerosis Drugs Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Multiple Sclerosis Drugs Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES MULTIPLE SCLEROSIS DRUGS MARKET FORECAST (2016-2021)

10.1 United States Multiple Sclerosis Drugs Sales, Revenue Forecast (2016-2021)
10.2 United States Multiple Sclerosis Drugs Sales Forecast by Type (2016-2021)
10.3 United States Multiple Sclerosis Drugs Sales Forecast by Application (2016-2021)
10.4 Multiple Sclerosis Drugs Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Multiple Sclerosis Drugs
Table Classification of Multiple Sclerosis Drugs
Figure United States Sales Market Share of Multiple Sclerosis Drugs by Type in 2015
Table Application of Multiple Sclerosis Drugs
Figure United States Sales Market Share of Multiple Sclerosis Drugs by Application in 2015
Figure United States Multiple Sclerosis Drugs Sales and Growth Rate (2011-2021)
Figure United States Multiple Sclerosis Drugs Revenue and Growth Rate (2011-2021)
Table United States Multiple Sclerosis Drugs Sales of Key Manufacturers (2015 and 2016)
Table United States Multiple Sclerosis Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Multiple Sclerosis Drugs Sales Share by Manufacturers
Figure 2016 Multiple Sclerosis Drugs Sales Share by Manufacturers
Table United States Multiple Sclerosis Drugs Revenue by Manufacturers (2015 and 2016)
Table United States Multiple Sclerosis Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Multiple Sclerosis Drugs Revenue Share by Manufacturers
Table 2016 United States Multiple Sclerosis Drugs Revenue Share by Manufacturers
Table United States Market Multiple Sclerosis Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Multiple Sclerosis Drugs Average Price of Key Manufacturers in 2015
Figure Multiple Sclerosis Drugs Market Share of Top 3 Manufacturers
Figure Multiple Sclerosis Drugs Market Share of Top 5 Manufacturers
Table United States Multiple Sclerosis Drugs Sales by Type (2011-2016)
Table United States Multiple Sclerosis Drugs Sales Share by Type (2011-2016)
Figure United States Multiple Sclerosis Drugs Sales Market Share by Type in 2015
Table United States Multiple Sclerosis Drugs Revenue and Market Share by Type (2011-2016)
Table United States Multiple Sclerosis Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Multiple Sclerosis Drugs by Type (2011-2016)
Table United States Multiple Sclerosis Drugs Price by Type (2011-2016)
Figure United States Multiple Sclerosis Drugs Sales Growth Rate by Type (2011-2016)
Table United States Multiple Sclerosis Drugs Sales by Application (2011-2016)
Table United States Multiple Sclerosis Drugs Sales Market Share by Application (2011-2016)
Figure United States Multiple Sclerosis Drugs Sales Market Share by Application in 2015
Table United States Multiple Sclerosis Drugs Sales Growth Rate by Application (2011-2016)
Figure United States Multiple Sclerosis Drugs Sales Growth Rate by Application (2011-2016)
Table Biogen Basic Information List
Table Biogen Multiple Sclerosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Biogen Multiple Sclerosis Drugs Sales Market Share (2011-2016)
Table Teva Pharmaceutical Basic Information List
Table Teva Pharmaceutical Multiple Sclerosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Teva Pharmaceutical Multiple Sclerosis Drugs Sales Market Share (2011-2016)
Table Merck KGaA Basic Information List
Table Merck KGaA Multiple Sclerosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck KGaA Multiple Sclerosis Drugs Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Multiple Sclerosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Multiple Sclerosis Drugs Sales Market Share (2011-2016)
Table Bayer Basic Information List
Table Bayer Multiple Sclerosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Multiple Sclerosis Drugs Sales Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Multiple Sclerosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi Multiple Sclerosis Drugs Sales Market Share (2011-2016)
Table Acorda Therapeutics Basic Information List
Table Acorda Therapeutics Multiple Sclerosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Acorda Therapeutics Multiple Sclerosis Drugs Sales Market Share (2011-2016)
Table Questcor Pharmaceuticals Basic Information List
Table Questcor Pharmaceuticals Multiple Sclerosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Questcor Pharmaceuticals Multiple Sclerosis Drugs Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Multiple Sclerosis Drugs
Figure Manufacturing Process Analysis of Multiple Sclerosis Drugs
Figure Multiple Sclerosis Drugs Industrial Chain Analysis
Table Raw Materials Sources of Multiple Sclerosis Drugs Major Manufacturers in 2015
Table Major Buyers of Multiple Sclerosis Drugs
Table Distributors/Traders List
Figure United States Multiple Sclerosis Drugs Production and Growth Rate Forecast (2016-2021)
Figure United States Multiple Sclerosis Drugs Revenue and Growth Rate Forecast (2016-2021)
Table United States Multiple Sclerosis Drugs Production Forecast by Type (2016-2021)
Table United States Multiple Sclerosis Drugs Consumption Forecast by Application (2016-2021)